Physician profile
April L Small
NPI 1225408206
$1,561.00
in general payments reported to CMS, 2019-2025
20 companies · $92.18 in 2025
The $92.18 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $529 · 2023: $492 · 2024: $165 · 2025: $92.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.16 |
| Education | $159.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $454.27 | 2021-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $241.75 | 2022-2025 | |
| Novo Nordisk INC | $187.61 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Amgen INC. | $122.42 | 2023 | Prolia |
| Glaxosmithkline, LLC. | $99.28 | 2021-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $67.87 | 2022-2024 | Breztri |
| Lilly USA, LLC | $65.84 | 2021-2023 | Mounjaro, Trulicity |
| Nestle Healthcare Nutrition INC. | $49.34 | 2021-2022 | |
| Pfizer INC. | $41.82 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.66 | 2021 | |
| Vivus LLC | $29.84 | 2021 | |
| Avanir Pharmaceuticals, INC. | $24.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.77 | 2022 | |
| Amarin Pharma, INC. | $19.43 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.42 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.35 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.95 | 2022 | |
| Esperion Therapeutics, INC. | $16.69 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.58 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.